Homo sapiens Protein: PEX5 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-16153.7 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | PEX5 | ||||||||||||||||||
Protein Name | peroxisomal biogenesis factor 5 | ||||||||||||||||||
Synonyms | PBD2A; PBD2B; PTS1-BP; PTS1R; PXR1; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000266564 | ||||||||||||||||||
InnateDB Gene | IDBG-16151 (PEX5) | ||||||||||||||||||
Protein Structure | |||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Binds to the C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type) and plays an essential role in peroxisomal protein import. {ECO:0000269PubMed:7706321, ECO:0000269PubMed:7719337, ECO:0000269PubMed:7790377}. | ||||||||||||||||||
Subcellular Localization | Cytoplasm. Peroxisome membrane; Peripheral membrane protein. Note=Its distribution appears to be dynamic. It is probably a cycling receptor found mainly in the cytoplasm and as well associated to the peroxisomal membrane through a docking factor (PEX13). | ||||||||||||||||||
Disease Associations | Peroxisome biogenesis disorder 2A (PBD2A) [MIM:214110]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and characterized clinically by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. {ECO:0000269PubMed:7719337}. Note=The disease is caused by mutations affecting the gene represented in this entry.Peroxisome biogenesis disorder 2B (PBD2B) [MIM:202370]: A peroxisome biogenesis disorder that includes neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), two milder manifestations of the Zellweger disease spectrum. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. Children with the NALD presentation may reach their teens, while patients with the IRD presentation may reach adulthood. The clinical conditions are often slowly progressive in particular with respect to loss of hearing and vision. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid. {ECO:0000269PubMed:10462504, ECO:0000269PubMed:7719337}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. {ECO:0000269PubMed:7706321, ECO:0000269PubMed:7719337, ECO:0000269PubMed:7790377}. | ||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 92 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR001440
Tetratricopeptide TPR1 IPR013026 Tetratricopeptide repeat-containing domain IPR019734 Tetratricopeptide repeat |
||||||||||||||||||
PFAM |
PF00515
PF13174 PF13176 PF13181 |
||||||||||||||||||
PRINTS | |||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00028
|
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | P50542 | ||||||||||||||||||
PhosphoSite | PhosphoSite-P50542 | ||||||||||||||||||
TrEMBL | F5H432 | ||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 5830 | ||||||||||||||||||
UniGene | Hs.567327 | ||||||||||||||||||
RefSeq | NP_000310 | ||||||||||||||||||
HUGO | HGNC:9719 | ||||||||||||||||||
OMIM | 600414 | ||||||||||||||||||
CCDS | CCDS8576 | ||||||||||||||||||
HPRD | 02684 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AC018653 AK292256 AK302742 AK316250 BC010621 CH471116 U19721 X84899 Z48054 | ||||||||||||||||||
GenPept | AAC50103 AAH10621 BAF84945 BAG63957 BAH14621 CAA59324 CAA88131 EAW88671 EAW88672 EAW88674 | ||||||||||||||||||